# LIDOCAINE HYDROCHLORIDE
> **ANDA216250** · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2022-03-23
## Drug
- **FDA Application Number:** ANDA216250
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIDOCAINE HYDROCHLORIDE
- **Generic name:** LIDOCAINE HYDROCHLORIDE
- **Active ingredients:** LIDOCAINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** NOVITIUM PHARMA
- **Manufacturer:** Novitium Pharma LLC
- **First approval:** 2022-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216250)
---
*AI Analytics · CC0 1.0*